Richard P. NgJr.

Richard P. NgJr.

Auto-generated profile, based on publicly available information

Richard P. NgJr.

Division of Cardiology and Cardiovascular Institute, Department of Medicine, University of California San Diego, La Jolla, CA, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2017 in Nature Medicine
Verified
Journal Article
Open access
PDF file
KKKevin R King
Kevin R King
AAAaron D Aguirre
Aaron D Aguirre
YYYu-Xiang Ye
Yu-Xiang Ye
YSYuan Sun
Yuan Sun
JRJason D Roh
Jason D Roh
RWRalph Weissleder
Ralph Weissleder
The massive cell death that occurs during myocardial infarction releases self-DNA and triggers an interferon response in infiltrating leukocytes via a cGAS–STING–IRF3 pathway. Interference with this response—either by genetic disruption of the pathway or antibody blockade of the type I interferon receptor—is beneficial in mice subjected to myocardial infarction. Interferon regulatory factor 3 (IRF3) and type I interferons (IFNs) protect against infections1 and cancer2, but excessive IRF3 activation and type I IFN production cause autoinflammatory conditions such as Aicardi–Goutières syndrome3,4 and STING-associated vasculopathy of infancy (SAVI)3. Myocardial infarction (MI) elicits inflammation5, but the dominant molecular drivers of MI-associated inflammation remain unclear. Here we show that ischemic cell death and uptake of cell debris by macrophages in the heart fuel a fatal response to MI by activating IRF3 and type I IFN production. In mice, single-cell RNA-seq analysis of 4,215 leukocytes isolated from infarcted and non-infarcted hearts showed that MI provokes activation of an IRF3–interferon axis in a distinct population of interferon-inducible cells (IFNICs) that were classified as cardiac macrophages. Mice genetically deficient in cyclic GMP-AMP synthase (cGAS), its adaptor STING, IRF3, or the type I IFN receptor IFNAR exhibited impaired interferon-stimulated gene (ISG) expression and, in the case of mice deficient in IRF3 or IFNAR, improved survival after MI as compared to controls. Interruption of IRF3-dependent signaling resulted in decreased cardiac expression of inflammatory cytokines and chemokines and decreased inflammatory cell infiltration of the heart, as well as in attenuated ventricular dilation and improved cardiac function. Similarly, treatment of mice with an IFNAR-neutralizing antibody after MI ablated the interferon response and improved left ventricular dysfunction and survival. These results identify IRF3 and the type I IFN response as a potential therapeutic target for post-MI cardioprotection.

25 September 2020 in Science Immunology
Verified
Journal Article
Closed access
DCDavid M. Calcagno
David M. Calcagno
RNRichard P. NgJr.
Richard P. NgJr.
ATAvinash Toomu
Avinash Toomu
CZClaire Zhang
Claire Zhang
KHKenneth Huang
Kenneth Huang
KKKevin R. King
Kevin R. King
The type I interferon response after myocardial infarction induces a cytoprotective Nrf2-dependent program in cardiac macrophages.